In genetically engineered mouse models (GEMMs) that yield BrafV600E- and Pten-deficient melanomas, tumor-specific ablation of Atg7 resulted in accumulation of defective mitochondria and impaired tumor growth. This evidence concerns the gene ATG7 and neoplasm.